a Radiation Protection Dosimetry and Calibration Group, Belgian Nuclear Research Centre (SCK•CEN), Belgium.
b Dosimetry and Calibration Department, Greek Atomic Energy Commission (EEAE), Agia Paraskevi, Greece.
Radiat Res. 2018 Apr;189(4):399-408. doi: 10.1667/RR14970.1. Epub 2018 Feb 6.
This study describes the retrospective lens dose calculation methods developed and applied within the European epidemiological study on radiation-induced lens opacities among interventional cardiologists. While one approach focuses on self-reported data regarding working practice in combination with available procedure-specific eye lens dose values, the second approach focuses on the conversion of the individual whole-body dose to eye lens dose. In contrast with usual dose reconstruction methods within an epidemiological study, a protocol is applied resulting in an individual distribution of possible cumulative lens doses for each recruited cardiologist, rather than a single dose estimate. In this way, the uncertainty in the dose estimate (from measurement uncertainty and variability among cardiologists) is represented for each individual. Eye lens dose and whole-body dose measurements have been performed in clinical practice to validate both methods, and it was concluded that both produce acceptable results in the framework of a dose-risk evaluation study. Optimal results were obtained for the dose to the left eye using procedure-specific lens dose data in combination with information collected on working practice. This method has been applied to 421 interventional cardiologists resulting in a median cumulative eye lens dose of 15.1 cSv for the left eye and 11.4 cSv for the right eye. From the individual cumulative eye lens dose distributions obtained for each cardiologist, maxima up to 9-10 Sv were observed, although with low probability. Since whole-body dose values above the lead apron are available for only a small fraction of the cohort and in many cases not for the entire working career, the second method has only been used to benchmark the results from the first approach. This study succeeded in improving the retrospective calculation of cumulative eye lens doses in the framework of radiation-induced risk assessment of lens opacities, but it remains dependent on self-reported information, which is not always reliable for early years. However, the calculation tools developed can also be used to make an assessment of the eye lens dose in current practice.
本研究描述了在欧洲介入心脏病学家辐射诱导晶状体混浊的流行病学研究中开发和应用的回顾性晶状体剂量计算方法。一种方法侧重于与可用的特定程序晶状体剂量值相关的工作实践的自我报告数据,而另一种方法侧重于将个体全身剂量转换为晶状体剂量。与流行病学研究中常用的剂量重建方法不同,本研究应用了一种方案,为每位招募的心脏病学家生成个体可能的累积晶状体剂量分布,而不是单一剂量估计。通过这种方式,代表了每个个体的剂量估计不确定性(来自测量不确定性和心脏病学家之间的变异性)。为了验证这两种方法,在临床实践中进行了晶状体剂量和全身剂量测量,得出的结论是,这两种方法在剂量风险评估研究框架内都产生了可接受的结果。使用特定程序的晶状体剂量数据与工作实践中收集的信息相结合,对左眼剂量进行了最佳优化。该方法已应用于 421 名介入心脏病学家,得出左眼累积晶状体剂量中位数为 15.1 cSv,右眼为 11.4 cSv。从每位心脏病学家获得的个体累积晶状体剂量分布中,可以观察到高达 9-10 Sv 的最大值,尽管概率较低。由于仅为队列的一小部分且在许多情况下不是整个工作生涯都提供了铅围裙以上的全身剂量值,因此仅使用第二种方法来对第一种方法的结果进行基准测试。本研究成功地改进了在晶状体混浊辐射风险评估框架内的累积晶状体剂量的回顾性计算,但它仍然依赖于自我报告的信息,这些信息并不总是可靠的,尤其是在早期。然而,开发的计算工具也可用于评估当前实践中的晶状体剂量。